Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components.
- DOI
- 10.1016/j.crphar.2021.100038
- Published
- 2021
- Container
- Current research in pharmacology and drug discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.crphar.2021.100038,
title = {Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components.},
author = {Verma D and Mitra D and Paul M and Chaudhary P and Kamboj A and Thatoi H and Janmeda P and Jain D and Panneerselvam P and Shrivastav R and Pant K and Das Mohapatra PK},
year = {2021},
journal = {Current research in pharmacology and drug discovery},
doi = {10.1016/j.crphar.2021.100038},
url = {https://doi.org/10.1016/j.crphar.2021.100038}
}RIS
TY - JOUR TI - Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components. AU - Verma D AU - Mitra D AU - Paul M AU - Chaudhary P AU - Kamboj A AU - Thatoi H AU - Janmeda P AU - Jain D AU - Panneerselvam P AU - Shrivastav R AU - Pant K AU - Das Mohapatra PK PY - 2021 JO - Current research in pharmacology and drug discovery DO - 10.1016/j.crphar.2021.100038 UR - https://doi.org/10.1016/j.crphar.2021.100038 ER -
APA
D, V., D, M., M, P., P, C., A, K., H, T., P, J., D, J., P, P., R, S., K, P., & PK, D. M. (2021). Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components.. Current research in pharmacology and drug discovery. https://doi.org/10.1016/j.crphar.2021.100038
Source records
- pubmed · retrieved 2026-09-26T22:39:13.169Z
- europe-pmc · retrieved 2026-09-26T22:39:13.186Z
- doaj · retrieved 2026-09-26T22:39:13.179Z